NEW BRUNSWICK (dpa-AFX) - Janssen-Cilag International NV, a subsidiary of Johnson & Johnson (JNJ), announced on Friday that the European Commission has approved Balversa or Erdafitinib ...

NEW BRUNSWICK (dpa-AFX) - Janssen-Cilag International NV, a Johnson & Johnson (JNJ) company, Friday said the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...